Press Releases on November 13, 2023 - EIN Presswire - Press Release Distribution Service

Published on November 13, 2023 - 21:05 GMT

180 Degree Capital Corp. Establishes Discount Management Program And Reports Net Asset Value Per Share (“Nav”) Of $4.91, Comprised ...

MONTCLAIR, N.J., Nov. 13, 2023 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180” and the “Company”), today announced a discount management program, reported its financial results as of September 30, 2023, and noted additional developments …

Distribution channels: Business & Economy ...

Published on November 13, 2023 - 21:05 GMT

Rezolute Reports First Quarter Fiscal 2024 Results

REDWOOD CITY, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced its financial …

Distribution channels: Business & Economy, Technology ...

Published on November 13, 2023 - 21:05 GMT

Aspira Women’s Health Reports Third Quarter 2023 Financial Results

Product revenue increased 9% to $2.2 million for the quarter, and 19% to $7.0 million year to date OvaSuite sales volume increased 5% to 5,783 units for the quarter, and 16% to 18,331 units year to date Third quarter cash utilization of $3.3 million, a …

Distribution channels:

Published on November 13, 2023 - 21:05 GMT

Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024

Seasoned Biotech Executive Pratik Shah Appointed as Chief Executive Officer to Lead Company Turnaround Current Cash and Securities of ~$290M Support Extended Five-Year Operating Runway Through 2028 Revised Corporate Strategy with Realignment Towards Long- …

Distribution channels: Business & Economy, Technology ...

Published on November 13, 2023 - 21:05 GMT

Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

- New Licensing Partnership with BioCryst Pharmaceuticals Expands Clearside’s Proprietary Suprachoroidal Injection Platform to Plasma Kallikrein Inhibitor - - BioCryst Collaboration Provides $5 Million Upfront, the Potential for Additional $77.5 Million in …

Distribution channels:

Published on November 13, 2023 - 21:05 GMT

Exagen Inc. Reports Strong Third Quarter 2023 Results

SAN DIEGO, California, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2023. Recognized total revenue of $13.4 million for …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 13, 2023 - 21:05 GMT

Espey Mfg. & Electronics Corp. reports first quarter results

SARATOGA SPRINGS, N.Y., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Espey Mfg. & Electronics Corp. (NYSE American: ESP) announces results for the first three months of fiscal year 2024. Net sales for the first quarter of fiscal year 2024, July 1 to September 30 …

Distribution channels:

Published on November 13, 2023 - 21:05 GMT

TILT Holdings Reports Third Quarter 2023 Results

PHOENIX, Nov. 13, 2023 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (NEO:TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 13, 2023 - 21:05 GMT

Y-mAbs Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

Q3 2023 DANYELZA® net product revenues of $20.0 million represents YoY growth of 59% U.S. FDA clearance of IND for CD38-SADA for relapsed or refractory non-Hodgkin Lymphoma Cash and cash equivalents of $86.6 million as of September 30, 2023, with …

Distribution channels:

Published on November 13, 2023 - 21:05 GMT

Westrock Coffee Company to Participate in the Stephens Annual Investment Conference

LITTLE ROCK, Ark., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Westrock Coffee Company (NASDAQ: WEST) (“Westrock Coffee” or the “Company”) today announced that the Company will be participating in the Stephens Annual Investment Conference, which will be held …

Distribution channels: Culture, Society & Lifestyle ...

Published on November 13, 2023 - 21:05 GMT

Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of ...

- Demonstrated improvements among best reported of fibrosis-reducing compounds - - Liver stiffness results complemented by positive changes in disease biomarkers and HepQuant Duo liver function test - “These findings presented today at AASLD The Liver …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on November 13, 2023 - 21:05 GMT

Reliance Global Group’s Revenue Grows by 16% for the Third Quarter of 2023

Working Capital Increases by $5.4 million Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, NJ, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance”, “we” or the “Company”), today provided a …

Distribution channels: Environment, Insurance Industry ...

Published on November 13, 2023 - 21:05 GMT

LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Entered into agreement with Bristol Myers Squibb for mavacamten in China and other Asian markets Phase 3 data from EXPLORER-CN trial of mavacamten presented in an oral late-breaking science session at the European Society of Cardiology Congress 2023 with …

Distribution channels: Business & Economy, Technology ...

Published on November 13, 2023 - 21:05 GMT

Globus Maritime Sets Date for the Release of Third Quarter and Nine Months 2023 Results

GLYFADA, Greece, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Globus Maritime Limited (“Globus” or the “Company”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that it will release financial results for the three- and nine-months period ended September …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 13, 2023 - 21:05 GMT

Sanara MedTech Inc. Announces Third Quarter 2023 Results

FORT WORTH, TX, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 13, 2023 - 21:05 GMT

Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

First case performed using the new FDA cleared Pure-Vu® EVS Gastro system, and expect to initiate broader market introductions by the end of 2023 Pure-Vu EVS Gastro addresses the Upper GI market, an area of high unmet clinical need, including approximately …

Distribution channels:

Published on November 13, 2023 - 21:05 GMT

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 ...

- Anticipate 510(k) filing for transformational Drug-Eluting Biomatrix CanGarooRM in Fourth Quarter SILVER SPRING, Md., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today …

Distribution channels:

Published on November 13, 2023 - 21:05 GMT

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

- Cyclacel Expects to Release Updated Phase 1/2 Clinical and Biomarker Data with Oral Fadraciclib and Provide Safety, Efficacy and Putative Mechanism Update for Oral Plogosertib - - Management to Host Conference Call at 4:30 pm ET Today - BERKELEY HEIGHTS …

Distribution channels:

Published on November 13, 2023 - 21:05 GMT

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024

Provides fiscal year 2025 revenue guidance of $12 - $16 million US pilot trial of LungFit® PRO to treat viral community acquired pneumonia (VCAP) underway with data expected mid-calendar 2024 Beyond Cancer presents positive first-in-human data for …

Distribution channels:

Published on November 13, 2023 - 21:05 GMT

UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the third …

Distribution channels: Business & Economy, Technology ...